MYGN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Myriad Genetics Inc

Watchlist Manager

Watchlist

Price: 6.18 USD -0.16% Market Closed

Market Cap: $583.7m

	Myriad Genetics Inc NASDAQ:MYGN	US
	Globalstar Inc NASDAQ:GSAT	US
	APA Group ASX:APA	AU
	WSP Global Inc TSX:WSP	CA
W	Webster Financial Corp F:WED	US
	Shimamura Co Ltd OTC:SHAOF	JP
M	Matsuda Sangyo Co Ltd TSE:7456	JP
	Serco Group PLC LSE:SRP	UK
	Huron Consulting Group Inc NASDAQ:HURN	US
	Bankinter SA MAD:BKT	ES
	Murata Manufacturing Co Ltd TSE:6981	JP
	MGP Ingredients Inc NASDAQ:MGPI	US
	Linde India Ltd BSE:523457	IN
B	Bank Negara Indonesia (Persero) Tbk PT XBER:BKE1	ID
S	Serco Group PLC DUS:SEO	UK
	Pfizer Inc NYSE:PFE	US
	MainStreet Bancshares Inc NASDAQ:MNSB	US
	Standard Bank Group Ltd F:SKC2	ZA
	Rio Tinto PLC LSE:RIO	UK
M	MillerKnoll Inc NASDAQ:MLKN	US
	Goldman Sachs BDC Inc NYSE:GSBD	US
U	Unisys Corp XMUN:USY1	US

Profitability Summary

Myriad Genetics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

68% > 70%

Negative Operating Margin

-8%

Negative 3Y Average Operating Margin

-14%

Operating Margin is Increasing

-26% > -8%

Negative Net Margin

-48%

Negative 3Y Average Net Margin

-32%

Declining Net Margin

-36% > -48%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-11%

Free Cash Flow Margin is Increasing

-17% > -3%

Negative ROE

-77%

Negative 3Y Average ROE

Negative 3Y Average ROIC